Page last updated: 2024-11-01

ofloxacin and Empyema, Pleural, Tuberculous

ofloxacin has been researched along with Empyema, Pleural, Tuberculous in 2 studies

Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elliott, AM1
Berning, SE1
Iseman, MD1
Peloquin, CA1
Yew, WW1
Lee, J1

Other Studies

2 other studies available for ofloxacin and Empyema, Pleural, Tuberculous

ArticleYear
Failure of drug penetration and acquisition of drug resistance in chronic tuberculous empyema.
    Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 1995, Volume: 76, Issue:5

    Topics: Aged; Antitubercular Agents; Chronic Disease; Empyema, Tuberculous; Ethambutol; Humans; Male; Ofloxa

1995
Drug treatment of chronic tuberculous empyema.
    Chest, 1992, Volume: 101, Issue:6

    Topics: Chronic Disease; Empyema, Tuberculous; Humans; Ofloxacin

1992